About Meta-IQ

About company

Meta-IQ is a Danish biotech company that develops innovative treatment for CNS diseases including secondary progressive multiple sclerosis (SP-MS), acute ocular neuritis (AON), Parkinson’s disease, amyotrophic lateral sclerosis (ALS) and depression by inhibiting CPT1 (the key molecule in fat metabolism) and thus resetting the energy metabolism from fatty-acid back to glucose resulting in neuro-protective and anti-inflammatory properties.